Mechanisms of follicular dysfunction in 46,XX spontaneous premature ovarian failure

Endocrinology and Metabolism Clinics of North America

Volumn 32, Issue 3, 2003, Pages 613-637

  Nelson, Lawrence M ^a   Bakalov, Vladimir K ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMENORRHEA; EARLY MENOPAUSE; FEMALE; FEMALE INFERTILITY; HUMAN; KARYOTYPE 46,XX; LUTEINIZATION; MENOPAUSE; OVARY FOLLICLE CELL; OVARY FUNCTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVIEW; TRANSVAGINAL ECHOGRAPHY; X CHROMOSOME ABERRATION;

FALLOPIA;

EID: 0141733238     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(03)00043-4     Document Type: Review

References (114)

1. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-6.
2. Alzubaidi NH, Chapin HL, Vanderhoof VH, Calis KA, Nelson LM. Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol 2002;99(5):720-5.
3. De Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril 1967;18:440-61.
4. Goldenberg RL, Grodin RL, Rodbard D, Ross GT. Gonadotropins in women with amenorrhea. Am J Obstet Gynecol 1973; 116:1003-9.
5. Schreiber JR, Davajan V, Kletzky OA. A case of intermittant ovarian failure. Am J Obstet Gynecol 1978;132:698-9.
6. Szlachter BN, Nachtigall LE, Epstein J, Young BK, Weiss G. Premature menopause: a reversible entity? Obstet Gynecol 1979;54:396-8.
7. Rebar RW, Erickson GF, Yen SSC. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 1982;37:35-41.
8. Nelson LM, Anasti JN, Flack MR. Premature ovarian failure. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery, and technology. New York: Raven Press; 1995. p. 1393-410.
9. van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5(5):483-92.
10. Baker TG. A quantitative and cytological study of germ cells in the human ovaries. Proc R Soc Lond 1963;158:417-33.
11. Baker TG, Sum OW. Development of the ovary and oogenesis. Clin Obstet Gynecol 1976;3:3-26.
12. Ohno S, Klinger HP, Atkin NB. Human oogenesis. Cytogenetics 1962;1:42-51.
13. Hughes FM Jr, Gorospe WC. Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia. Endocrinol 1991;129:2415-22.
14. Thomford PJ, Jelovsek FR, Mattison DR. Effect of oocyte number and rate of atresia on the age of menopause. Reprod Toxicol 1987;1:41-51.
15. Tilly JL. Commuting the death sentence: how oocytes strive to survive. Nat Rev Mol Cell Biol 2001;2(11):838-48.
16. Markstrom E, Svensson EC, Shao R, Svanberg B, Billig H. Survival factors regulating ovarian apoptosis-dependence on follicle differentiation. Reproduction 2002;123(1):23-30.
17. Mattison DR, Thomford PJ, Jelovsek FR. Disposition of oocytes and age at menopause. N Engl J Med 1988;318:644.
18. Picton HM. Activation of follicle development: the primordial follicle. Theriogenology 2001;55(6):1193-210.
19. Matzuk MM, Burns KH, Viveiros MM, Eppig JJ. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 2002;296(5576):2178-80.
20. Hirshfield AN. Comparison of granulosa cell proliferation in small follicles of hypophysectomized, prepubertal, and mature rats. Biol Reprod 1985;32:979-87.
21. Richards JS, Russell DL, Ochsner S, Hsieh M, Doyle KH, Falender AE, et al. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 2002;57:195-220.
22. Eppig JJ, Wigglesworth K, Pendola FL. The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc Natl Acad Sci USA 2002;99(5):2890-4.
23. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:804-10.
24. van Kasteren YM, Hundscheid RD, Smits AP, Cremers FP, van Zonneveld P, Braat DD. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod 1999;14(10):2455-9.
25. Mehta AE, Matwijiw I, Lyons EA, Faiman C. Noninvasive diagnosis of resistant ovary syndrome by ultrasonography. Fertil Steril 1992;57:56-61.
26. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994;79:1470-5.
27. Menon V, Edwards RL, Butt WR, Bluck M, Lynch SS. Review of 59 patients with hypergonadotrophic amenorrhoea. Br J Obstet Gynaecol 1984;91:63-6.
28. Irvine WJ, Chan MMW, Scarth L, Kolb FO, Hartog M, Bayliss RIS, et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 1968;2:883-90.
29. Turkington RW, Lebovitz HE. Extra-adrenal endocrine deficiencies in Addison's disease. Am J Med 1967;43:499-507.
30. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322:1829-36.
31. Bannatyne P, Russell P, Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 1990;9:191-207.
32. Biscotti CV, Hart WR, Lucas JG. Cystic ovarian enlargement resulting from autoimmune oophoritis. Obstet Gynecol 1989;74:492-5.
33. Case records of the Massachusetts General Hospital CC Case 46-1986. N Engl J Med 1986;315:1336-43.
34. Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol 1993;39:35-43.
35. Betterle C, Volpato M. Adrenal and ovarian autoimmunity. Eur J Endocrinol 1998;138:16-25.
36. Friedman CI, Gurgen-Varol F, Lucas J, Neff J. Persistent progesterone production associated with autoimmune oophoritis. J Reprod Med 1987;32:293-6.
37. Rabinowe SL, Berger MJ, Welch WR, Dluhy RG. Lymphocyte dysfunction in autoimmune oophoritis. Am J Med 1986;81:347-50.
38. Russell P, Bannatyne P, Shearman RP, Fraser IS, Corbett P. Premature hypergonadotropic ovarian failure: clinicopathological study of 19 cases. Int J Gynecol Pathol 1982;1:185-201.
39. Sedmak DD, Hart WR, Tubbs RR. Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int J Gynecol Pathol 1987;6:73-81.
40. Somerville JE, Iftikhar M, O'Sullivan JF, Hayes D. Autoimmune oophoritis. An incidental finding. Pathol Res Pract 1993;189:475-80.
41. Burrell LM, Murdoch A, Angus B, White MC. Autoimmune ovarian failure with elevated serum levels of luteinizing hormone and enlarged ovaries. Case report. Br J Obstet Gynaecol 1990;97(4):362-4.
42. Fox R. Autoimmune ovarian failure with elevated serum levels of luteinizing hormone and enlarged ovaries. Br J Obstet Gynaecol 1991;98(1):115-6.
43. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997;18:107-34.
44. Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A, et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril 2002;78(2):270-9.
45. Kalantaridou SN, Braddock DT, Patronas NJ, Nelson LM. Treatment of autoimmune premature ovarian failure. Hum Reprod 1999;14(7):1777-82.
46. Rivier C, Vale W. In the rat, interleukin-1α acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion. Endocrinology 1992;124:2105-9.
47. Larrea F, Lisker R, Banuelos R, Bermudez JA, Herrera J, Rasilla VN, et al. Hypergonadotrophic hypogonadism in an XX female subject due to 17,20 steroid desmolase deficiency. Acta Endocrinol 1983;103:400-5.
48. Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002;17(8):2096-100.
49. LaBarbera AR, Miller MM, Ober C, Rebar RW. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol 1988;16:115-22.
50. Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975;55:699-706.
51. Yong EL, Baird DT, Yates R, Reichert LE Jr., Hillier SG. Hormonal regulation of the growth and steroidogenic function of human granulosa cells. J Clin Endocrinol Metab 1992;74:842-9.
52. Doody KJ, Lorence MC, Mason JI, Simpson ER. Expression of messenger ribonucleic acid species encoding steroidogenic enzymes in human follicles and corpora lutea throughout the menstrual cycle. J Clin Endocrinol Metab 1990;70:1041-5.
53. Lacker HM, Ethan A. How do the ovaries count? Math Biosci 1988;90:305-32.
54. Duncan M, Cummings L, Chada K. Germ cell deficient (gcd) mouse as a model of premature ovarian failure. Biol Reprod 1993;49:221-7.
55. Stevens ML, Plotka ED. Functional lutein cyst in a postmenopausal woman. Obstet Gynecol 1977;50:27S-9S.
56. Strickler RC, Kelly RW, Askin FB. Postmenopausal ovarian follicle cyst: an unusual cause of estrogen excess. Int J Gynecol Pathol 1984;3:318-22.
57. Coulam CB. Premature gonadal failure. Fertil Steril 1982;38:645-55.
58. Elvin JA, Matzuk MM. Mouse models of ovarian failure. Rev Reprod 1998;3(3):183-195.
59. Yan C, Matzuk MM. Transgenic models of ovarian failure. J Soc Gynecol Investig 2001;8(Suppl):S30-3.
60. Bione S, Sala C, Manzini C, Arrigo G, Zuffardi O, Banfi S, et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 1998;62(3):533-41.
61. Besmer P, Manova K, Duttlinger R, Huang EJ, Packer A, Gyssler C, et al. The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. Development 1993;(Suppl):125-37.
62. Shibanuma K, Tong ZB, Vanderhoof V, Vanevski K, Nelson L. Investigation of KIT gene mutations in women with 46,XX spontaneous premature ovarian failure. BMC Womens Health 2002;2(1):8.
63. Hertz R. Comments. In: Villee CA, editor. Control of ovulation. New York: Pergamon Press; 1961. p. 221.
64. Hertz R. Pituitary independence of the prepubertal development of the ovary of the rat and the rabbit and its pertinence to hypo-ovarianism in women. In: Grady HG, Smith DE, editors. The ovary. Baltimore, MD: Williams & Wilkins; 1963. p. 120-7.
65. Jones GS, De Moraes-Ruehsen M. A new syndrome of amenorrhea in association with hypergonadotropism and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol 1969;104:597-600.
66. Nishi Y, Hamamoto K, Kajiyama M, Kawamura I. The Perrault syndrome: clinical report and review. Am J Med Genet 1988;31:623-9.
67. Conway GS, Hettiarachchi S, Murray A, Jacobs PA. Fragile X premutation in familial premature ovarian failure. Lancet 1995;346:309-10.
68. Schwartz CE, Dean J, Howard-Peebles PN, Bugge M, Mikkelsen M, Tommerup N, et al. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet 1994;51:400-2.
69. Simpson JL, Christakos AC, Horwith M, Silverman FS. Gonadal dysgenesis in individuals with apparently normal chromosomal complements: tabulation of cases and compilation of genetic data. Birth Defects 1971;7:215-28.
70. Smith A, Fraser IS, Noel M. Three siblings with premature gonadal failure. Fertil Steril 1979;32(5):528-30.
71. Granat M, Amar A, Mor-Yosef S, Brautbar C, Schenker JG. Familial gonadal germinative failure: endocrine and human leukocyte antigen studies. Fertil Steril 1983;40(2):215-9.
72. Youlton R, Michelsen H, Be C, Cruz-Coke R. Pure XX gonadal dysgenesis in identical twins. Clin Genet 1982;21(4):262-5.
73. Purandare VN, Sathe AV. Gonadal dysgenesis variants in sisters: a hitherto undescribed combination. Int J Gynaecol Obstet 1979;16(5):416-8.
74. Aleem FA. Familial 46,XX gonadal dysgenesis. Fertil Steril 1981;35(3):317-20.
75. Mattison DR, Evans MI, Schwimmer WB, White BJ, Jensen B, Schulman JD. Familial premature ovarian failure. Am J Hum Genet 1984;36:1341-8.
76. Turner G, Robinson H, Wake S, Martin N. Dizygous twinning and premature ovarian failure in fragile X syndrome. Lancet 1994;344:1500.
77. Maxson WS, Wentz AC. The gonadotropin resistant ovary syndrome. Semin Reprod Endocrinol 1983;1:147-60.
78. Chiauzzi V, Cigorraga S, Escobar ME, Rivarola MA, Charreau EH. Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins. J Clin Endocrinol Metab 1982;54:1221-8.
79. Kuki S, Morgan RL, Tucci JR. Myasthenia gravis and premature ovarian failure. Arch Intern Med 1981;141:1230-2.
80. Anasti JN, Flack MR, Froehlich J, Nelson LM. The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J Clin Endocrinol Metab 1995;80:824-8.
81. Aittomaki K. The genetics of XX gonadal dysgenesis. Am J Hum Genet 1994;54(5):844-51.
82. Aittomaki K, Lucena JLD, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959-68.
83. Aittomaki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 1996;81(10):3722-6.
84. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest 1998;102(7):1352-9.
85. Jiang M, Aittomaki K, Nilsson C, Pakarinen P, Iitia A, Torresani T, et al. The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. J Clin Endocrinol Metab 1998;83(12):4338-43.
86. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol 1999;13(11):1844-54.
87. Takakura K, Takebayashi K, Wang HQ, Kimura F, Kasahara K, Noda Y. Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome. Fertil Steril 2001;75(1):207-9.
88. Fonte Kohek MB, Batista MC, Russell AJ, Vass K, Giacaglia LR, Mendonca BB, et al. No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure. Fertil Steril 1998;70(3):565-7.
89. Latronico AC, Anasti J, Arnhold IJ, Rapaport R, Mendonca BB, Bloise W, et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996;334(8):507-12.
90. Toledo SPA, Brunner HG, Kraaij R, Post M, Dahia PLM, Hayashida CY, et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 1996;81(11):3850-4.
91. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981;304:994-8.
92. Waggoner DD, Buist NRM, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inher Metab Dis 1990;13:802-18.
93. Fraser IS, Russell P, Greco S, Robertson DM. Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia. Clin Reprod Fertil 1986;4:133-8.
94. Fraser IS, Shearman RP, Smith A, Russell P. An association among blepharophimosis, resistant ovary syndrome, and true premature menopause. Fertil Steril 1988;50:747-51.
95. Panidis D, Rousso D, Vavilis D, Skiadopoulos S, Kalogeropoulos A. Familial blepharophimosis with ovarian dysfunction. Hum Reprod 1994;9:2034-7.
96. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001;27(2):159-66.
97. Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 2002;8(8):729-33.
98. Weinstein LS, Chen M, Liu J. Gs(alpha) mutations and imprinting defects in human disease. Ann N Y Acad Sci 2002;968:173-97.
99. Wolfsdorf JI, Rosenfield RL, Fang VS, Kobayashi R, Razdan AK, Kim MH. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol 1978;88:321-8.
100. Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 2001;30(1):101-19.
101. Rabinovici J, Blankstein J, Goldman B, Rudak E, Dor Y, Pariente D, et al. In vitro fertilization and primary embryonic cleavage are possible in 17α-hydroxylase deficiency despite extremely low intrafollicular 17β-estradiol. J Clin Endocrinol Metab 1989;68:693-7.
102. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994;78(6):1287-92.
103. Nelson LM, Bakalov V, Pastor C. Ovarian insufficiency. Available at: http://www. emedicine.com/MED/topic3374.htm. eMed J [serial online] 2002; 1-14.
104. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285(6):785-95.
105. Davies MC, Hall ML, Jacobs HS. Bone mineral loss in young women with amenorrhoea. BMJ 1990;301(6755):790-3.
106. Mishell DRJ, Stenchever MA, Droegemueller W, Herbst AL. Primary and secondary amenorrhea. Comprehensive gynecology. St. Louis, MO: Mosby; 1997. p. 1043-67.
107. Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1997;89(5):777-9.
108. Tidey GF, Nelson LM, Phillips TM, Stillman RJ. Gonadotropins enhance HLA-DR antigen expression in human granulosa cells. Am J Obstet Gynecol 1992;167:1768-73.
109. Nelson LM. Spontaneous premature ovarian failure: young women, special needs. Menopause Manage 2001;10:1-6.
110. Sauer MV, Paulson RJ, Lobo RA. A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med 1990;323:1157-60.
111. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288(3):321-33.
112. Alper MM, Jolly EE, Garner PR. Pregnancies after premature ovarian failure. Obstet Gynecol 1986;67:59S-62S.
113. Mishell DR Jr., Nakamura RM, Crosignani PG, Stone S, Kharma K, Nagata Y, et al. Serum gonadotropin and steroid patterns during the normal menstrual cycle. Am J Obstet Gynecol 1971;111(1):60-5.
114. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. The Writing Group for the PEPI trial. JAMA 1996;275(5):370-5.